|
1
|
Turner JJ, Morton LM, Linet MS, Clarke CA,
Kadin ME, Vajdic CM, Monnereau A, Maynadié M, Chiu BC,
Marcos-Gragera R, et al: InterLymph hierarchical classification of
lymphoid neoplasms for epidemiologic research based on the WHO
classification (2008): Update and future directions. Blood.
116:e90–e98. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Harris NL, Jaffe ES, Diebold J, Flandrin
G, Muller-Hermelink HK, Vardiman J, Lister TA and Bloomfield CD:
The World Health Organization classification of neoplastic diseases
of the hematopoietic and lymphoid tissues. Report of the clinical
advisory committee meeting, Airlie house, Virginia, November, 1997.
Ann Oncol. 10:1419–1432. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
van Besien K, Ha CS, Murphy S, McLaughlin
P, Rodriguez A, Amin K, Forman A, Romaguera J, Hagemeister F,
Younes A, et al: Risk factors, treatment, and outcome of central
nervous system recurrence in adults with intermediate-grade and
immunoblastic lymphoma. Blood. 91:1178–1184. 1998.PubMed/NCBI
|
|
4
|
Blum KA, Lozanski G and Byrd JC: Adult
Burkitt leukemia and lymphoma. Blood. 104:3009–3020. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hecht JL and Aster JC: Molecular biology
of Burkitt's lymphoma. J Clin Oncol. 18:3707–3721. 2000.PubMed/NCBI
|
|
6
|
ar-Rushdi A, Nishikura K, Erikson J, Watt
R, Rovera G and Croce CM: Differential expression of the
translocated and the untranslocated c-myc oncogene in Burkitt
lymphoma. Science. 222:390–393. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Johnson KA, Tung K, Mead G and Sweetenham
J: The imaging of Burkitt's and Burkitt-like lymphoma. Clin Radiol.
53:835–841. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cairo MS, Gerrard M, Sposto R, Auperin A,
Pinkerton CR, Michon J, Weston C, Perkins SL, Raphael M, McCarthy
K, et al: Results of a randomized international study of high-risk
central nervous system B non-Hodgkin lymphoma and B acute
lymphoblastic leukemia in children and adolescents. Blood.
109:2736–2743. 2007.PubMed/NCBI
|
|
9
|
Klein G: Burkitt lymphoma-a stalking horse
for cancer research? Semin Cancer Biol. 19:347–350. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hayday AC, Gillies SD, Saito H, Wood C,
Wiman K, Hayward WS and Tonegawa S: Activation of a translocated
human c-myc gene by an enhancer in the immunoglobulin heavy-chain
locus. Nature. 307:334–340. 1984. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Miles RR, Arnold S and Cairo MS: Risk
factors and treatment of childhood and adolescent Burkitt
lymphoma/leukaemia. Br J Haematol. 156:730–743. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pui CH and Thiel E: Central nervous system
disease in hematologic malignancies: Historical perspective and
practical applications. Semin Oncol. 36(4): Suppl 2. S2–S16. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jang SJ, Yoon DH, Kim S, Yoon S, Kim DY,
Park CS, Huh J, Lee SW, Lee DH, Rvu JS and Suh C: A unique pattern
of extranodal involvement in Korean adults with sporadic Burkitt
lymphoma: A single center experience. Ann Hematol. 91:1917–1922.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Crivii SM, Neamtu S and Bocsan G:
Neuroimmunitary profile estimation in cerebrospinal fluid and its
importance in childhood acute lymphoblastic leukaemia. Arch
Geschwulstforsch. 59:199–204. 1989.PubMed/NCBI
|
|
15
|
Yadav J and Jain V: Cushing syndrome
related to leukemic infiltration of the central nervous system. J
Pediatr Endocrinol Metab. 28:717–719. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bromberg JE, Breems DA, Kraan J, Bikker G,
van der Holt B, Smitt PS, van den Bent MJ, van't Veer M and Gratama
JW: CSF flow cytometry greatly improves diagnostic accuracy in CNS
hematologic malignancies. Neurology. 68:1674–1679. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Quijano S, López A, Sancho J Manuel,
Panizo C, Debén G, Castilla C, García-Vela J Antonio, Salar A,
Alonso-Vence N, González-Barca E, et al: Identification of
leptomeningeal disease in aggressive B-cell non-Hodgkin's lymphoma:
Improved sensitivity of flow cytometry. J Clin Oncol. 27:1462–1469.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Carrillo-Cruz E, Marín-Oyaga VA, Solé
Rodríguez M, Borrego-Dorado I, de la Cruz Vicente F, Quiroga
Cantero E, Manzanares Pérez M, Capote FJ, Ramírez Sánchez MJ,
Espigado Tocino I, et al: Role of 18F-FDG-PET/CT in the management
of Burkitt lymphoma. Eur J Haematol. 94:23–30. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Just PA, Fieschi C, Baillet G, Galicier L,
Oksenhendler E and Moretti JL: 18F-fluorodeoxyglucose positron
emission tomography/computed tomography in AIDS-related Burkitt
lymphoma. AIDS Patient Care STDS. 22:695–700. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mintzer DM, Andreeff M, Filippa DA,
Jhanwar SC, Chaganti RS and Koziner B: Progression of nodular
poorly differentiated lymphocytic lymphoma to Burkitt's-like
lymphoma. Blood. 64:415–421. 1984.PubMed/NCBI
|
|
21
|
Mead GM, Barrans SL, Qian W, Walewski J,
Radford JA, Wolf M, Clawson SM, Stenning SP, Yule CL, Jack AS, et
al: A prospective clinicopathological study of dose modified
CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined
using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10
trial). Blood. 112:2248–2260. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Smeland S, Blystad AK, Kvaløy SO, Ikonomou
IM, Delabie J, Kvalheim G, Hammerstrøm J, Lauritzsen GF and Holte
H: Treatment of Burkitt's/Burkitt-like lymphoma in adolescents and
adults: A 20-year experience from the Norwegian Radium Hospital
with the use of three successive regimens. Ann Oncol. 15:1072–1078.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Todeschini G, Bonifacio M, Tecchio C,
Balter R, Carli G, Stefani PM, Adami F, Zamò A, Dei Tos AP, Marino
F, et al: Intensive short-term chemotherapy regimen induces high
remission rate (over 90%) and event-free survival both in children
and adult patients with advanced sporadic Burkitt
lymphoma/leukemia. Am J Hematol. 87:22–25. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Thomas DA, Faderl S, O'Brien S,
Bueso-Ramos C, Cortes J, Garcia-Manero G, Giles FJ, Verstovsek S,
Wierda WG, Pierce SA, et al: Chemoimmunotherapy with hyper-CVAD
plus rituximab for the treatment of adult Burkitt and Burkitt-type
lymphoma or acute lymphoblastic leukemia. Cancer. 106:1569–1580.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Barnes JA, Lacasce AS, Feng Y, Toomey CE,
Neuberg D, Michaelson JS, Hochberg EP and Abramson JS: Evaluation
of the addition of rituximab to CODOX-M/IVAC for Burkitt's
lymphoma: A retrospective analysis. Ann Oncol. 22:1859–1864. 2011.
View Article : Google Scholar : PubMed/NCBI
|
